Personal CFO Solutions LLC Purchases 592 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Personal CFO Solutions LLC raised its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 11.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,811 shares of the company’s stock after purchasing an additional 592 shares during the period. Personal CFO Solutions LLC’s holdings in U.S. Physical Therapy were worth $516,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in USPH. Venturi Wealth Management LLC lifted its position in U.S. Physical Therapy by 3,200.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock worth $64,000 after buying an additional 704 shares during the last quarter. KBC Group NV raised its holdings in U.S. Physical Therapy by 68.6% during the 3rd quarter. KBC Group NV now owns 774 shares of the company’s stock valued at $66,000 after buying an additional 315 shares during the last quarter. Pacer Advisors Inc. bought a new position in shares of U.S. Physical Therapy during the fourth quarter valued at about $113,000. First Horizon Advisors Inc. raised its position in U.S. Physical Therapy by 25.1% during the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock valued at $126,000 after purchasing an additional 298 shares during the last quarter. Finally, Mutual of America Capital Management LLC purchased a new stake in U.S. Physical Therapy in the fourth quarter worth $203,000.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. JPMorgan Chase & Co. raised their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. William Blair reaffirmed a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $100.00 to $115.00 in a report on Monday, December 16th. Barrington Research lowered their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. Finally, Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, U.S. Physical Therapy presently has an average rating of “Moderate Buy” and an average target price of $111.50.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the company’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. This represents a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.70% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Price Performance

Shares of U.S. Physical Therapy stock opened at $80.61 on Monday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The stock’s fifty day moving average is $87.21 and its 200 day moving average is $87.56. The stock has a market cap of $1.22 billion, a P/E ratio of 85.76, a P/E/G ratio of 3.54 and a beta of 1.51. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). The company had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. Sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be paid a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 2.23%. The ex-dividend date of this dividend is Friday, March 14th. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s payout ratio is currently 97.83%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.